Talman Pizzey - Feb 14, 2025 Form 3 Insider Report for ACUREN CORP (TIC)

Role
Chief Executive Officer
Signature
/s/ Fiona Sutherland, Attorney in Fact
Stock symbol
TIC
Transactions as of
Feb 14, 2025
Transactions value $
$0
Form type
3
Date filed
2/14/2025, 04:30 PM
Next filing
Apr 15, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding TIC Common Stock 400K Feb 14, 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding TIC Restricted Stock Units Feb 14, 2025 Common Stock 110K Direct F1, F2
holding TIC Performance Based Restricted Stock Units Feb 14, 2025 Common Stock 110K Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These restricted stock units vest 33 1/3% on the first through third anniversaries of the grant date (July 30, 2024).
F2 Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock.
F3 Subject to the volume weighted average price ("VWAP") of the Issuer's Common Stock reaching $20.00 over a ten (10) consecutive trading day period at any time during the period commencing on the date on which the Common Stock is listed on the New York Stock Exchange and ending on July 30, 2029 (the "VWAP Achievement Period"), these performance based restricted stock units shall vest on the later of (x) July 30, 2025 and the calendar day following the last day of the VWAP Achievement Period.
F4 Each performance based restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock.

Remarks:

See Exhibit 24.1 - Power of Attorney